Normal view MARC view ISBD view

Im, S H

Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Jun 2001 - 6893-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

ISSN: 0022-1767

Standard No.: 10.4049/jimmunol.166.11.6893 doi

Subjects--Topical Terms:
Abatacept
Animals
Antibody Specificity
Antigens, CD
Antigens, Differentiation--biosynthesis
B-Lymphocytes--immunology
CD40 Ligand--immunology
CTLA-4 Antigen
Cell Differentiation--immunology
Cells, Cultured
Chronic Disease
Cytokines--biosynthesis
Down-Regulation--immunology
Female
Humans
Hypersensitivity, Delayed--immunology
Immune Sera--administration & dosage
Immunoconjugates
Immunoglobulin G--biosynthesis
Immunoglobulin Isotypes--biosynthesis
Immunosuppressive Agents--administration & dosage
Injections, Intraperitoneal
Injections, Subcutaneous
Lymphocyte Activation--immunology
Myasthenia Gravis, Autoimmune, Experimental--immunology
Rats
Rats, Inbred Lew
Receptors, Cholinergic--administration & dosage
Th1 Cells--immunology
Th2 Cells--immunology
Torpedo--immunology
Up-Regulation--immunology